Literature DB >> 8016760

Infection with Mycobacterium kansasii.

P D Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8016760      PMCID： PMC474860          DOI： 10.1136/thx.49.5.435

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  18 in total

1.  Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.

Authors:  G D Harris; W G Johanson; D P Nicholson
Journal:  Am Rev Respir Dis       Date:  1975-07

2.  Treatment of infections in patients with the acquired immunodeficiency syndrome.

Authors:  D Armstrong; J W Gold; J Dryjanski; E Whimbey; B Polsky; C Hawkins; A E Brown; E Bernard; T E Kiehn
Journal:  Ann Intern Med       Date:  1985-11       Impact factor: 25.391

3.  The reaction to PPD-Battey. A new look.

Authors:  G Wijsmuller; P Erickson
Journal:  Am Rev Respir Dis       Date:  1974-01

Review 4.  NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations.

Authors:  A S Fauci; A M Macher; D L Longo; H C Lane; A H Rook; H Masur; E P Gelmann
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

5.  Nontuberculous mycobacteria and disease.

Authors:  P A Jenkins
Journal:  Eur J Respir Dis       Date:  1981

6.  Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.

Authors:  J Banks; P A Jenkins; A P Smith
Journal:  Tubercle       Date:  1985-09

7.  Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.

Authors:  C H Ahn; J R Lowell; S S Ahn; S I Ahn; G A Hurst
Journal:  Am Rev Respir Dis       Date:  1983-12

8.  Pulmonary infection with mycobacterium xenopi: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

9.  Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

10.  Treatment of pulmonary infections caused by mycobacteria of the Mycobacterium avium-intracellulare complex.

Authors:  A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139
View more
  9 in total

1.  A molecular approach to identification and profiling of first-line-drug-resistant mycobacteria from sputum of pulmonary tuberculosis patients.

Authors:  Imran Hussain Chowdhury; Aditi Sen; Bojlul Bahar; Avijit Hazra; Urmita Chakraborty; Subhadip Choudhuri; Avranil Goswami; Nishith Kumar Pal; Basudev Bhattacharya
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

2.  Clinical implications of Mycobacterium kansasii species heterogeneity: Swiss National Survey.

Authors:  Caroline Taillard; Gilbert Greub; Rainer Weber; Gaby E Pfyffer; Thomas Bodmer; Stefan Zimmerli; Reno Frei; Stefano Bassetti; Peter Rohner; Jean-Claude Piffaretti; Enos Bernasconi; Jacques Bille; Amalio Telenti; Guy Prod'hom
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.

Authors:  N Al Jarad; P Demertzis; D J Jones; N C Barnes; R M Rudd; H Gaya; J A Wedzicha; D T Hughes; D W Empey
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

4.  Pulmonary Mycobacterium kansasii infection: comparison of radiological appearances with pulmonary tuberculosis.

Authors:  A J Evans; A J Crisp; R B Hubbard; A Colville; S A Evans; I D Johnston
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

5.  Pulmonary Mycobacterium kansasii infection: comparison of the clinical features, treatment and outcome with pulmonary tuberculosis.

Authors:  S A Evans; A Colville; A J Evans; A J Crisp; I D Johnston
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

6.  Increasing reports of non-tuberculous mycobacteria in England, Wales and Northern Ireland, 1995-2006.

Authors:  Jonathan E Moore; Michelle E Kruijshaar; L Peter Ormerod; Francis Drobniewski; Ibrahim Abubakar
Journal:  BMC Public Health       Date:  2010-10-15       Impact factor: 3.295

7.  Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.

Authors:  D Shitrit; R Priess; N Peled; G Bishara; D Shlomi; M R Kramer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-10       Impact factor: 3.267

Review 8.  Tuberculosis in the elderly. Epidemiology and optimal management.

Authors:  P D Davies
Journal:  Drugs Aging       Date:  1996-06       Impact factor: 3.923

9.  Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii.

Authors:  Joyce Wang; Fiona McIntosh; Nicolas Radomski; Ken Dewar; Roxane Simeone; Jost Enninga; Roland Brosch; Eduardo P Rocha; Frédéric J Veyrier; Marcel A Behr
Journal:  Genome Biol Evol       Date:  2015-02-25       Impact factor: 3.416
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.